Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock

Core Points - Lifecore Biomedical, Inc. has successfully closed a $24.3 million private placement of 5,928,775 shares at a price of $4.10 per share, aimed at funding working capital, operations, and general corporate purposes [1] - The investment group consists of both new and existing shareholders, indicating confidence in the company's management and growth strategy [2] - Lifecore is a fully integrated contract development and manufacturing organization (CDMO) specializing in sterile injectable pharmaceutical products, with over 40 years of experience in manufacturing injectable-grade hyaluronic acid [5]